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ScienceDirectUnderstanding the past is to understand the present.
Mammalian life, with all its complexity comes from a humble
beginning of a single fertilized egg cell. Achieving this requires
an enormous diversification of cellular function, the majority of
which is generated through a series of cellular decisions during
embryogenesis. The first decisions are made as the embryo
prepares for implantation, a process that will require
specialization of extra-embryonic lineages while preserving an
embryonic one. In this mini-review, we will focus on the mouse
as a mammalian model and discuss recent advances in the
decision making process of the early embryo.
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Introduction
In mammals, a new generation begins when an oocyte is
fertilized by a sperm to form a zygote. From this point
until the embryo implants, cell fate decisions revolve
around the partitioning of the two extra-embryonic
lineages and the embryonic one. Cleavage divides the
zygote into blastomeres without increasing its size and by
E3.5 a cavity will have formed within the embryo to
distinguish two cell populations: the extra-embryonic
trophectoderm (TE), a one-cell thick layer of epitheli-
al-like cells surrounding the pluripotent inner cell mass
(ICM) that lies to one side of the cavity. This lineage
specification process is referred to as the first cell fate
decision (Figure 1). A further differentiation event will
occur within the ICM, setting apart the primitive endo-
derm (PE) and the epiblast (EPI) in the second cell fate
decision. The PE is another extra-embryonic lineage that
will develop into the yolk sac, and the EPI is the truly
embryonic lineage that will form the embryo proper. Bywww.sciencedirect.com E4.5 the PE cells will have moved to the cavity side of the
ICM, so that the embryonic lineage is coated by the PE
on one side and TE on the other. This is the final product
of pre-implantation development, and the embryo is
ready to implant. Thus pre-implantation cell fate deci-
sions address whether to be or not to be an epiblast cell.
Morphogenetic cues for cell fate
Intensive research has been carried out on the underlying
mechanisms of cell fate specification in the pre-implan-
tation embryo. In many vertebrates, the zygote has a
defined axis with asymmetrically distributed determi-
nants ready to instruct cell fate. In the mammalian zygote,
a polarized cell fate determinant either doesn’t exist or
has yet to be discovered. Earlier work was focused on
determining the existence of an initial cue that would
break symmetry to specify the first embryonic axis, the
embryonic-abembryonic axis, as defined by the position
of the ICM. Possible cues could relate to the sperm entry
point and the position of the polar bodies, which are
byproducts of asymmetric meiotic divisions that mark the
‘animal pole’ of the animal-vegetal axis (AV axis) of the
zygote. Our research among others observed a bias be-
tween the polarity of the zygote and the contribution to
distinct cell lineages that depends on the orientation and
order of the cell divisions to the 4-cell stage [1–4]. But
others have not observed any fate bias in cell fate [5–9] or
proposed that the mechanical constraint of the zona
pellucida leads to specification of the embryonic-abem-
bryonic axis [9]. Supportive evidence for symmetry
breaking by the 4-cell stage comes from the finding that
when the same 4-cell stage blastomeres are combined
together, the resulting embryos differ in developmental
potential depending whether their cells originate from
animal or vegetal pole [10,11]. Recent genetic tracing
using the Rainbow transgenic mouse confirmed that
indeed individual blastomeres of the 4-cell embryos differ
and show a bias towards a particular cell fate [12]. Such
discrepancies likely arose due to the highly sensitive
nature of early mouse embryos and also various technical
limitations. Mouse embryos are remarkably plastic. Even
within the same litter, embryos can exhibit different
developmental dynamics, can compensate for experimen-
tal manipulations and are the antithesis of eutelic organ-
isms such as nematodes that follow a deterministic
developmental program. Technical limitations also ham-
per attempts to understand this period of development.
The few number of cells in these embryos precludes use
of conventional biochemical techniques applied in tradi-
tional cell biology. Furthermore these embryos essentiallyCurrent Opinion in Genetics & Development 2015, 34:71–76
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Overview of key cell fate decision events during pre-implantation development. During the first four and a half days of mouse development the
free-floating embryo undergoes cleavage and differentiates extra-embryonic lineages from the embryonic one. The fertilized egg, also known as
the zygote, lacks polarization of any known cell fate determinant. Little is known about the molecular mechanism of cell fate specification in these
early stages up until the 4-cell stage, where blastomeres express different levels of epigenetic regulators, and each blastomere has a bias towards
a particular lineage. Compaction at the 8-cell stage allows the generation of inside/outside (IN/OUT) cells, the first time where blastomeres take on
physically different positions within the embryo. Inside cells are more likely to form the ICM while outside cells is predisposed to the
trophectoderm. The process in which this occurs has generally been termed the first cell fate decision. After the formation of the blastocyst cavity
at E3.5, some cells in the ICM will start to express markers of the primitive endoderm and sort towards the cavity side of the ICM. This process is
called the second cell fate decision and produces the second extra-embryonic lineage of the embryo.have two transcriptomes: one inherited from the oocyte
and the newly combined zygotic transcriptome. This ma-
ternal-to-zygotic transition is very poorly understood and
complicates various genetic approaches. To breakthrough
these barriers requires a new generation of technology, and
with recent progress in techniques such as single-cell
sequencing and live imaging, it may become possible to
shed more light on this mysterious period of development.
Molecular regulators of cell fate before
compaction
The challenge now is to account for the findings about
early asymmetry in molecular terms. Epigenetic differ-
ences have been found between blastomeres as early as
the 4-cell stage. The epigenetic regulator Prdm14 is
heterogeneously expressed between 4-cell stage blasto-
meres and artificially elevating levels of H3 methylation
via Prdm14 or Carm1, another epigenetic modifier, directs
cells to the epiblast fate [13,14]. However, it is still not
clear how this early heterogeneity becomes established.
The intracellular kinetics of exogenously introduced
Oct4 also differentially influence cell fate already at
the 4-cell stage [15] but it will take further work to
understand the significance of this and of how well it
represents the behavior of endogenous Oct4. Later on in
development, compaction at the 8-cell stage provides
mature cell-cell contacts that are crucial for polarization
and cell fate decisions [16,17], but what regulates the
timing of this process remains mysterious. During com-
paction the mRNA of the key TE determinant Cdx2
localizes to the apical domain of blastomeres, mirroring
mechanisms for localization of developmentally impor-Current Opinion in Genetics & Development 2015, 34:71–76 tant transcripts in other non-mammalian vertebrate and
invertebrate embryos. This localization of Cdx2 tran-
scripts contributes to a process whereby Cdx2 expression
becomes restricted to outside cells, thus biasing those
cells to become TE [18]. Cdx2 is maternally deposited as
well as zygotically transcribed, and the role of maternal
Cdx2 has been of debate. Although it has been suggested
that maternal Cdx2 is dispensable [19,20], the elimination
of both maternal and zygotic Cdx2 leads to defects in TE
specification at the cleavage stages, thus earlier than when
only zygotic Cdx2 is eliminated [21,22].
Molecular regulators of cell fate after
compaction
Compaction eliminates intercellular space and allows
blastomeres to divide asymmetrically enabling them to
populate the inside of the embryo. This marks the first
time where distinct, ‘inside’ or ‘outside’, populations of
blastomeres emerge. Members of the Hippo signaling
pathway play a crucial role in setting up the differential
lineage bias of these two populations. When the Hippo
pathway is activated, the kinases Lats1/2 phosphorylate
the transcriptional co-activators Yap/Taz [23–25]. Yap/
Taz phosphorylation results in their cytoplasmic seques-
tering and, consequently, their target genes are not
expressed [25]. In ES cells, Yap has been reported to
promote pluripotency [26,27], which is mediated through
a Yap-Tead2 interaction [27]. However, in the embryo
Yap has a different mode of function as instead of Tead2
[28], Tead4 is required for successful pre-implantation
development [29,30]. TE genes such as Cdx2 and
Eomes are not expressed in most Tead4/ embryoswww.sciencedirect.com
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[29,30], suggesting Tead4 is an activator gene for the TE
fate. Despite being a TE regulator, Tead4 is expressed
constitutively in all cells of the blastocyst [29]. However,
its function is differentially controlled by the differential
localization of Yap/Taz. An active Hippo pathway in
inside cells sequesters Yap/Taz from the nucleus, Tead4
is not activated and the cells take on an ICM fate. In
contrast in outside cells the Hippo pathway is inactive,
Yap/Taz activates Tead4 and the TE program is
switched on [31]. The other Hippo pathway kinase
Mst1/2 does not seem to feature in YAP localization in
the pre-implantation embryo [32].
Polarization of the Par complex is a known determinant
for the TE fate [33], however there was no molecular
pathway linking it to nuclear transcription. Recent prog-
ress identified the junction-associated protein Angiomo-
tin (Amot) as the missing link. Amot is distributed apically
in outside cells but does not show any polarity in inside
cells [34,35]. Amot is able to activate Lats in the inside
cells as well as sequester Yap independently [34,35].
Downregulating polarity components such as Pard6b or
disrupting aPKC function via dominant negative con-
structs results in an apolar distribution of Amot in outside
cells. Consequently these outside cells have cytoplasmic
Yap and Cdx2 is not expressed. Furthermore, Amot can
be phosphorylated and activated by Lats, suggesting a
positive feedback loop [34]. Another upstream compo-
nent of the Hippo pathway, Nf2, has also been identified
as a cell fate regulator. Nf2 mutant embryos fail to
phosphorylate YAP in the inside cells, and the phenotype
is compounded in a maternal-zygotic mutant, indicating
Nf2 is also maternally supplied. Nf2 has been proposed to
function in the adherens junction complex along with
Amot, therefore Nf2 and Amot may be functionally
linked [32,34].
Apart from the Hippo signaling pathway, Notch signaling
also appears involved in the first cell fate decision. Analy-
sis of an upstream cis-regulatory enhancer of Cdx2
revealed that Notch signaling cooperates with Tead4 to
ensure sufficient activation of Cdx2 in the TE, and over-
expression of the Notch1 intracellular domain (NICD) is
able to drive blastomeres to the TE [36]. However, Notch
signaling does not affect expression of other TE genes
such as Eomes or Gata3 indicating that it is not required
for the overall development of the TE [36].
Low oxygen bypasses Tead4 requirement
Recently, the Hippo/Tead4-centric viewpoint was put
into question by a study that cultured embryos in low
oxygen (5%), which more closely resemble the in vivo
environment, rather than the conventionally used atmo-
spheric level (21%) [37]. Under 5% O2 Tead4
/ em-
bryos were able to develop to the blastocyst stage as well
as express TE marker genes such as Cdx2, Eomes, Gata3www.sciencedirect.com and Elf5. This surprising but important finding indicates
Tead4 may actually be dispensable for TE development.
However Tead4/ embryos were reported to arrest their
development at E3.5 in vivo, without a well-defined TE
[30,37]. It was hypothesized that oxidative stress-induc-
ing metabolic substrates present in vivo but not in vitro
was the cause for this discrepancy. Supplementing the in
vitro culture media with glucose, essential amino acids
and glutamine caused Tead4/ embryos in low oxygen
to arrest in development, similar to their counterparts
developing in vivo. Furthermore, addition of an antioxi-
dant was able to rescue Tead4/ embryos under other-
wise non-permissive conditions. Together these results
suggest Tead4 protects the embryo from oxidative stress,
and without oxidative stress Tead4 becomes dispensable
for TE development [37]. But why should Tead4/
embryos have a TE-specific phenotype? This could be
because the TE is much more enriched in mitochondria
than the ICM [10,11], and uses oxidative phosphorylation
while the ICM uses glycolysis [11,22]. The high energy
consumption in the TE is likely used to drive expansion
of the blastocyst cavity. Therefore it is possible that
Tead4 (and also the Hippo pathway) acts as a protective
measure for the TE, rather than a true cell fate determi-
nant. Such a finding reveals there is still a lot more to be
learnt about the first cell fate decision.
Rise of the primitive endoderm
The second cell fate decision differentiates the EPI from
PE within the ICM, but this process may begin much
earlier, before the ICM is formed. The timing of blasto-
mere internalization affects the probability of it becoming
PE or EPI: blastomeres internalized in the first round of
asymmetric division (8- to 16-cell stage) are more likely to
become EPI, and those internalized in the second or third
round of asymmetric division (16- to 32-cell stage and 32-
to 64-cell stage) are more likely to become PE [38]. This
was not observed in another study [39], but was recently
validated by a third group [40]. This bias was found to be
due to differential levels of Fgfr2 [41]. FGF signaling is a
known component for PE formation [39], and blastomeres
internalized in the second wave upregulate Fgfr2, there-
by becoming more sensitive to FGF signaling essential
for PE formation [41]. Nanog-expressing cells in the ICM
produce FGF [42] and although FGF signaling is the
limiting factor for the amount of PE cells, it is not
required for the initial expression of PE markers [43].
Recent work suggests a role for Oct4 in PE formation, in
agreement with the previously known role of Oct4 and
Sox2 in lineage priming [44]. Thus, in the embryo Oct4
appears to be required for the expression of FGF, main-
tenance of early PE marker Gata6 and for the expression
of late PE markers Sox17 and Pdgfra [45,46]. Mature PE
cells acquire apical-basal polarity and the apical polarity
marker aPKC is found to take part in the second cell fate
decision as well as the first. aPKC is enriched in PE
progenitors and after cell sorting within the ICM, aPKCCurrent Opinion in Genetics & Development 2015, 34:71–76
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Figure 2
Integrated model of the first and second cell fate decision
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An integrated model of the first and second cell fate decision. Molecular determinants that can be consolidated into a connected network are
shown. Lines between the first and second cell fate decisions are blurred after the discovery that Tead4, the central protein of the first cell
decision, downregulates Sox2 expression, and that Sox2 can promote the PE fate. Spanning both the first and second cell fate decisions, this
could provide the molecular basis for the PE bias of blastomeres internalized later in development. All of the pathways shown are elucidated
through culturing embryos under atmospheric oxygen levels. Low oxygen levels relieve the Tead4 requirement for trophectoderm formation and
opens up the question whether Tead4 is a true cell fate determinant.becomes polarized at the cavity interface. Disrupting
aPKC function results in failure in TE formation [33]
as well as in PE sorting and maturation [47], which links
first and the second cell fate decision process. PDGF
signaling is also involved in PE formation. This pathway
appears independent of the FGF pathway and does not
affect lineage commitment or cell sorting, but rather PE
cell survival [48].
Parts of a whole: integrating the two cell fate
decisions
Thus far the first and second cell fate decision have been
treated as separate events, but the lines have been blurred
after recent discoveries that both BMP signaling [49] and
also Sox2 [50] play a role in both. A deep sequencing
screen of different cell populations within the embryo
revealed previously anticipated, pre-implantation role of
BMP signaling [49,51]. Interfering with the functions of
various BMP signaling components leads to impaired
development of both extra-embryonic lineages while
the EPI lineage develops normally [49,51]. Tead4 down-
regulates Sox2 expression in the outside cells, indepen-
dently of Cdx2, making Sox2 the first pluripotency factor
to be restricted to the inside cells at the morula stage. After
the first cell fate decision, Sox2 then specifies the PE by
upregulating PE genes via FGF4, as well as maintaining
EPI gene expression [50]. This falls in line with an
integrated cell fate model, where prolonged exposure toCurrent Opinion in Genetics & Development 2015, 34:71–76 TE determinants would bias blastomeres to the PE when
their progenies become positioned inside (Figure 2).
Conclusion
Despite a rapidly expanding field, we have much to learn
about the mechanisms that underlie transition from toti-
potency to embryonic pluripotency and from embryonic
pluripotency to lineage specification in the embryo. Most
of our current knowledge is concentrated upon the later
stages, where some molecular determinants are known. In
contrast, our understanding of the earlier stages, especial-
ly before compaction, is far from complete. We have yet
to piece together the growing evidence for the influence
of early events upon cell fate choices into a coherent
picture. Consolidation of all of these findings will give us
insight into the earliest cues leading to exit from totipo-
tency to pluripotency and finally to lineage specification.
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